RPS6KB1 and neoplasm: The results showed that the expressions of ASNS, mTORC1 pathways (p-S6K, p-S6 and p-4EBP1) and Ki67 in the tumor tissues treated with CCT196969 were significantly lower than that in the control group (Supplementary Fig. 3A).